Hemogenic refers to a rare subset of cells lining embryonic blood vessels that possess the ability to generate blood. These cells, collectively called hemogenic endothelium, look and behave like ordinary vascular cells for a brief window during development, then undergo a dramatic identity switch and produce the blood-forming stem cells that will supply an organism’s entire blood system for life. The concept reshapes how biologists think about the origin of blood: rather than arising from some separate tissue, blood cells are born directly from the walls of blood vessels themselves.
What Hemogenic Endothelium Actually Is
During early embryonic development, a small fraction of the endothelial cells lining certain blood vessels acquire a hidden potential. They still express the surface markers of blood vessel cells, still participate in forming the vessel wall, but they carry an internal program that primes them to become something else entirely. This specialized population is called hemogenic endothelium, and it exists only briefly during a narrow developmental window in specific tissues, including the yolk sac and a region of the embryo known as the aorta-gonad-mesonephros, or AGM.1PubMed Central. Specification and function of hemogenic endothelium during embryogenesis
What makes these cells remarkable is the transition they undergo. A hemogenic endothelial cell loosens its connections to neighboring vessel-wall cells, rounds up, and physically buds off into the bloodstream as a newly minted blood stem or progenitor cell.2Genes & Development. Opening the window for endothelial-to-hematopoietic transition Researchers call this the endothelial-to-hematopoietic transition, or EHT, and it is one of the most striking examples of cellular identity change found in nature. A cell that was part of a blood vessel literally becomes a blood cell.
How the Transition Unfolds at the Cellular Level
Watching EHT happen under a microscope (which live imaging in zebrafish and mouse embryos has made possible) reveals an almost violent physical transformation. Hemogenic endothelial cells break apart their tight junctions with neighboring endothelial cells, contract, and bulge outward from the vessel wall. They then detach and enter the bloodstream as blood stem and progenitor cells.3Genes & Development. Opening the window for endothelial-to-hematopoietic transition This whole process takes only hours per cell, and only a small number of endothelial cells ever make the switch.
Single-cell gene-expression studies have tried to capture what distinguishes hemogenic cells from their non-blood-forming neighbors. One study using human embryonic stem cell-derived cells compared hemogenic endothelial cells, ordinary vascular endothelial cells, and early blood progenitors at the individual-cell level. Hemogenic cells and blood progenitors were enriched in many of the same genes and shared a developmental pathway, while ordinary endothelial cells were transcriptionally distinct and more varied from cell to cell.4PubMed Central. Single Cell Resolution of Human Hematoendothelial Cells Defines Transcriptional Signatures of Hemogenic Endothelium In other words, hemogenic endothelium is already partway to being blood, even while it still sits in the vessel wall.
In the mouse AGM, single-cell profiling revealed that the shift from pre-hemogenic to fully hemogenic endothelium is not a sudden flip but a continuous gradient. Researchers found that the enzyme ACE marks this entire continuum, rising steadily as cells progress toward a blood-forming state.5Blood. Murine AGM single-cell profiling identifies a continuum of hemogenic endothelium differentiation marked by ACE That gradual transition matters because it suggests the process can be stalled, accelerated, or diverted at multiple points, something with implications for efforts to recreate it in the lab.
The Genetic Switches Behind the Change
The master regulator of EHT is a gene called RUNX1. Without it, hemogenic endothelium forms but the cells never complete their transition into blood cells. Forcing RUNX1 on in ordinary embryonic endothelial cells can drive them through EHT and produce blood progenitors, though the trick works much less efficiently in fetal or adult endothelial cells.6PubMed Central. Efficient hemogenic endothelial cell specification by RUNX1 is dependent on baseline chromatin accessibility of RUNX1-regulated TGFβ target genes That age-dependent decline in responsiveness hints that the chromatin landscape of young endothelial cells is uniquely permissive, with the relevant genes in an “open” configuration that RUNX1 can read.
RUNX1 does not act alone. The Notch signaling pathway plays a dual and somewhat counterintuitive role. Strong Notch signaling, driven by one ligand called Dll4, pushes endothelial cells toward an arterial identity, keeping them as vessel-wall cells. But a competing ligand, Jag1, delivers a weaker Notch signal that instead supports the hemogenic program. The balance between these two ligands determines whether a given endothelial cell stays arterial or tips toward blood formation.7Nature Communications. Notch signal strength controls cell fate in the haemogenic endothelium It is a tug of war where the strength of the same pathway, not just its presence or absence, decides the outcome.
A related piece of the puzzle involves the transcription factor SOX17. Research has shown that genes associated with arterial identity, including SOX17 and Notch1 itself, must be actively turned down for blood-forming clusters to emerge from the vessel wall. When researchers deleted SOX17 in endothelial cells at the right time, EHT increased. Conversely, cranking up Notch signaling in those same SOX17-deficient cells canceled the extra blood formation.8Nature Communications. Repression of arterial genes in hemogenic endothelium is sufficient for haematopoietic fate acquisition The implication is elegant: hemogenic cells do not just turn on blood genes. They must also actively silence their vessel-wall identity.
Blood Flow as a Trigger
The genetic switches described above do not fire in a vacuum. Physical forces from the embryo’s developing circulation play a critical role in activating the hemogenic program. This makes intuitive sense: hemogenic endothelium lines blood vessels, so it is constantly exposed to the mechanical stress of flowing blood.
One particularly revealing set of experiments used a “dorsal aorta on a chip,” a miniaturized lab device that mimics the pulsing stretch of blood flow on vessel-wall cells. Researchers found that cyclic stretch activated a signaling protein called YAP in hemogenic endothelium. When they blocked YAP activity in zebrafish embryos, blood stem cell production in the main embryonic artery dropped. When they overexpressed an always-active form of YAP, blood stem cell numbers rose.9Developmental Cell. Hemodynamic Forces to YAP Signaling Activate Human Hemogenic Endothelium YAP turned out to be essential not for initiating the hemogenic program, but for maintaining and maturing it once it began. The mechanical tug of blood flow, translated through a chain of molecular signals involving Rho GTPases upstream of YAP, effectively sustains the transition.
More broadly, biomechanical cues of various kinds, including the stiffness of surrounding tissue, friction from fluid flow, and the physical constraints of adhesion, have emerged as important regulators of blood stem cell behavior both in the embryo and, potentially, in adult bone marrow.10PubMed. Force of change: How biomechanical cues drive endothelial plasticity and morphogenesis The recognition that purely mechanical inputs can steer cell fate has opened up a new dimension of research beyond the traditional focus on chemical signals and gene regulation.
Inflammation Before There Is Anything to Inflame
Perhaps the most surprising discovery about hemogenic endothelium is that inflammatory signals, typically associated with infection and tissue damage, are required for blood stem cell emergence in the embryo. This happens well before any immune system exists to fight pathogens, suggesting inflammation has a constructive developmental role that predates its defensive one.
Studies in zebrafish and mice demonstrated that tumor necrosis factor (TNF), a classic inflammatory molecule, signals through its receptor TNFR2 to activate the Notch and NF-κB pathways in hemogenic endothelium, and that this activation is necessary for blood stem cell emergence.11Cell. TNF Signaling is Required for Hematopoietic Stem Cell Emergence Separately, the innate immune receptor TLR4, known in adult biology for detecting bacterial components, was found to drive hemogenic endothelium development through NF-κB signaling, which in turn feeds into Notch activity.12PubMed. Inflammatory signaling regulates hematopoietic stem and progenitor cell emergence in vertebrates The fact that the embryo co-opts pathways usually reserved for fighting infection to build its blood system is one of the more fascinating twists in developmental biology.
These findings also carry practical weight. If inflammatory signaling is a necessary ingredient for making blood stem cells, then protocols aimed at generating blood stem cells in the lab from pluripotent stem cells need to account for it. Ignoring the inflammatory input could explain why some early lab recipes for blood cell production stalled at the progenitor stage and never produced true long-term engrafting stem cells.
Primitive Blood Versus Definitive Blood
Not all hemogenic endothelium is the same. The embryo produces blood in successive waves. The earliest wave, called primitive hematopoiesis, generates a short-lived set of red blood cells and some immune cell precursors. These are stop-gap cells that keep the embryo oxygenated while the permanent system comes online. Definitive hematopoiesis, which arrives later, produces the blood stem cells capable of self-renewal and of generating every blood cell type for the lifetime of the organism.
Both waves originate from hemogenic endothelium, but from distinct populations. In the mouse yolk sac, a marker called LYVE1 traced by genetic labeling was found in definitive blood progenitors and a type of precursor called erythro-myeloid progenitors, but not in primitive red blood cells, suggesting these lineages diverge early and represent fundamentally different branches of blood formation.13PubMed Central. LYVE1 Marks the Divergence of Yolk Sac Definitive Hemogenic Endothelium from the Primitive Erythroid Lineage
In human embryonic stem cell models, researchers tracked the kinetics of hemogenic endothelium differentiation and identified multiple progenitor populations emerging from the same starting pool. The earliest emerging cells rapidly lost endothelial markers and were restricted to making primitive red blood cells. A later-emerging population retained endothelial markers longer, responded to Notch pathway manipulation, and produced red cells, white cells, and T lymphocytes, hallmarks of definitive hematopoiesis with lymphoid potential.14Stem Cell Reports. Early Human Hemogenic Endothelium Generates Primitive and Definitive Hematopoiesis In Vitro That lymphoid potential is the critical dividing line: only definitive hematopoietic cells can build an adaptive immune system.
Making Blood Cells in the Lab
One of the biggest practical motivations for studying hemogenic endothelium is the possibility of manufacturing blood stem cells from human pluripotent stem cells. If researchers can recapitulate the natural hemogenic program in a dish, they could produce transplantable blood stem cells for patients with leukemia, bone marrow failure, or genetic blood disorders without needing a matched donor.
Several protocols now guide pluripotent stem cells through mesoderm formation and into hemogenic endothelium. A common approach uses a bone morphogenetic protein called BMP4 to drive mesoderm, a GSK3β inhibitor to push toward definitive hematopoiesis, and VEGF along with other cytokines to support blood cell emergence.15PubMed. Directed differentiation of definitive hemogenic endothelium and hematopoietic progenitors from human pluripotent stem cells An alternative, simplified protocol demonstrated that a single Wnt pathway activator could drive pluripotent stem cells all the way to hemogenic endothelium without any hematopoietic cytokines at all, yielding a large number of cells with the surface markers of hemogenic endothelium and the functional ability to undergo definitive blood formation.16PubMed Central. Cytokine-free directed differentiation of human pluripotent stem cells efficiently produces hemogenic endothelium with lymphoid potential
The cytokine-free approach is worth noting because it strips the process to its essentials and suggests that the Wnt signal alone is a potent driver of hemogenic fate. For practical cell manufacturing, fewer ingredients means lower cost, simpler quality control, and easier regulatory approval. Still, making hemogenic endothelium in a dish is only half the problem. The cells that emerge from these protocols are progenitors, not fully functional long-term repopulating stem cells equivalent to those found in adult bone marrow. Bridging that gap is the field’s central unsolved challenge.
Why the Mechanical Environment Matters for Lab Production
The discovery that blood flow and mechanical stretch regulate hemogenic endothelium in the embryo has prompted researchers to incorporate physical forces into their lab protocols. Conventional cell culture grows cells on flat, static surfaces, which bear little resemblance to the pulsatile interior of an embryonic artery. That mismatch may account for some of the difficulty in producing fully functional blood stem cells in vitro.
The dorsal aorta-on-a-chip experiments showed that wall shear stress and cyclic stretch both increased expression of RUNX1, the master regulator of EHT, in human hemogenic endothelium. Critically, the mechanical signal acted through a specific molecular chain involving Rho GTPases and YAP, and drugs targeting that chain could stimulate blood stem cell production both in the chip and in zebrafish.17Developmental Cell. Hemodynamic Forces to YAP Signaling Activate Human Hemogenic Endothelium That last finding is especially promising because it means the effect of blood flow might be replicated pharmacologically, without building complex bioreactors.
Bioreactor-based approaches are also being explored. By exposing hemogenic endothelium cultures to controlled fluid flow, researchers hope to push progenitors further along the maturation pathway than static culture allows. The broader principle, that mechanical context is not just a backdrop but an active instructor of cell fate, has reshaped how the field designs differentiation protocols.
The Metabolic Side of Hemogenic Fate
Cells making the transition from endothelium to blood also rewire their metabolism. Endothelial cells are famously glycolytic, meaning they prefer to burn sugar rapidly without heavy reliance on oxygen-dependent energy pathways. Blood stem cells, by contrast, shift toward oxidative metabolism during definitive hematopoiesis. Acetyl-CoA metabolism, a product of the oxygen-dependent pathway, has been linked to the epigenetic changes that lock in the blood-forming identity of newly minted stem cells.18World Journal of Stem Cells. Metabolic-epigenetic nexus in regulation of stem cell fate
The connection between metabolism and gene regulation is not coincidental. Acetyl-CoA is the raw material for acetylation, a chemical modification that opens up DNA packaging and makes genes accessible. During EHT, the shift in metabolic fuel may literally open the chromatin regions that RUNX1 and other transcription factors need to read. If that model holds, it would explain why the chromatin landscape becomes less permissive in older endothelial cells: their metabolic profile has already settled into a pattern that no longer supports the necessary epigenetic remodeling. For lab protocols, this raises the possibility that adjusting culture media composition, for instance by providing metabolic substrates that favor oxidative phosphorylation, could improve the efficiency of blood stem cell generation.
Hemogenic Endothelium Beyond the AGM
For years, the AGM region received the lion’s share of attention as the birthplace of blood stem cells. But hemogenic endothelium has been found in additional embryonic sites. The yolk sac produces both primitive and definitive blood progenitors from its own hemogenic endothelium. More recently, the placenta has been identified as yet another source. One study in mouse embryos described the placenta as a “newly defined source” of hemogenic endothelium and tissue-resident macrophages, expanding the map of where blood formation occurs during development.19Developmental Cell. Placenta is a newly defined source of hemogenic endothelium and macrophages in the developing mouse embryo
The existence of multiple hemogenic sites raises the question of whether all hemogenic endothelium is equivalent. Current evidence suggests it is not. AGM hemogenic endothelium gives rise to bona fide blood stem cells capable of long-term engraftment, while yolk sac hemogenic endothelium predominantly generates shorter-lived progenitors and tissue-resident immune cells. Placental hemogenic endothelium may contribute both categories, though its precise output is still being mapped. These differences likely trace back to the distinct signaling environments at each anatomical site, including different combinations of Notch, Wnt, inflammatory, and mechanical cues. Understanding what makes AGM hemogenic endothelium uniquely capable of producing long-term stem cells remains one of the field’s most important open questions, and potentially the key to finally producing transplantable stem cells in the lab.